Share:
Image
Overview
Body
Event Secondary Body
When Acquisition Isn't the Answer: Building, Shaping, and Sustaining Strategic Partnerships
Featured Speaker, Dina Vaysman, Senior Director of Transactions at Johnson & Johnson, draws on her experience in precision oncology to explore how companies create and sustain value through long-term strategic partnerships - particularly when outright acquisition is not possible or practical.
Precision oncology requires large pharmaceutical companies to forge enduring partnerships with diagnostic companies that operate under fundamentally different business models, incentive structures, risk profiles, and economics. Dina will share what it takes to set those partnerships up for success - from early development through full commercialization.
Topics Dina will discuss include:
- When and why partnering beats buying - reframing value creation beyond M&A
- Aligning incentives across asymmetric partners - working across organizations with different business models, scale, and risk tolerance
- Designing partnerships end-to-end - managing interdependencies and ensuring flexibility
- Governance that holds - building in frameworks that ensure coordination through inflection points, shifting priorities, and leadership changes
Dina Vaysman is Senior Director of Transactions at Johnson & Johnson. She brings over a decade of transactional experience across J&J's Pharmaceutical, Medical Device, and Consumer Health sectors, having executed more than $20 billion in deal value across >40 transactions. Before joining J&J, she was an investment banking associate at Greenhill & Co. and a strategy consultant at Accenture. Dina holds a Bachelor of Engineering from Cornell University and an MBA from Columbia Business School. |
| Thank you to our CD Forum Co-Hosts: David Blaskey, COO, AVIS/BUDGET Car & Truck Rentals, Ctrl PA/N/Ctrl NJ Brian Buchert, Head of Corporate Strategy and M&A, Church & Dwight Pierce Cleary, Senior Director of Business Development & Strategy, Radius Recycling Mark Kuehn, Founding Chairman, ACG NJ, Principal, The DAK Group Renée Monteyne, Professional Development Director, FBT Gibbons P.C. Robin Sitver, VP Corporate Development, Board Member, Tempo Therapeutics Vinay Torani, Director, Blue Matter Consulting LLC |
The CD Forum is a quarterly dinner meeting/ discussion forum for Corporate Development Officers (CDOs) and other M&A, Transactional and Strategy executives, generally from larger corporations. Over the 15 years of the Forum more than 200 CDO's have attended, with many current "regulars." A typical dinner discussion group has a CDO leading the discussion on an important topic of interest, with 15 to 25 CDOs attending. Who else can attend?
NOTE: Firms that directly compete with forum sponsors may not attend. These events are designed for peer discussion, not selling. |
Hosted by: ACG
Chapter
New Jersey
Event Materials
Event Materials
Registration Fees:
Early Bird Rates Expire April 16, 2026
Member - ACG $75 EB | $100
Non-Member $75 EB | $125
Please Note: This forum is by invitation only. If you have registered but do not meet the criteria to attend, we reserve the right to cancel your registration.
CLICK TO REQUEST AN INVITATION
Cancellation policy: Cancellations must be received in writing more than 72 hours in advance for a refund to be issued for most events. An admin fee may apply.
A 3% payment processing fee will be added to credit and debit card transactions. This fee covers non-refundable costs charged by our payment processor and does not represent surplus for ACG.
